Exabis Library
Welcome to the e-CCO Library!
P675 CT-Scout platform, the digital solution to boost patient recruitment in inflammatory bowel disease clinical trials: A multicentre prospective observational comparative study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P675: Associations between Inflammatory Bowel Disease, social isolation, and mortality: evidence from UK Biobank cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P675: Flavonoid-degrading bacteria have central positions in correlation network analysis in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P675: Follow-up ileocolonoscopy is underused in Crohn’s disease patients after ileocecal resection despite higher total and inpatient health care costs compared with controls without resection
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P675: Infliximab biosimilar CT-P13 therapy is effective in maintaining clinical remission in Crohn's disease and ulcerative colitis – 54 week data
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P675: Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, safety and impact of extraintestinal manifestations and immunomediated diseases
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P675: The relationship between gender, severity of disease, treatment type, and employment outcome in patients with inflammatory bowel disease in Israel
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P676 Faecal monitoring is useful in monitoring treatment response in anti-TNF-treated patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P676: Burden of depression and anxiety among inflammatory bowel disease patients in a national cohort in Israel – Data from the EPI-IIRN
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P676: Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P676: Correlation of lipid levels with reduction in inflammation in patients with ulcerative colitis: Data from the tofacitinib OCTAVE clinical trials
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P676: Intestinal ultrasound accurately predicts therapy failure in Crohn's disease patients during a biologics-induced remission
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P676: The impact to disease activity, iron and vitamin D deficiency on fatigue in IBD patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P676: The small intestinal microbiome in Crohn’s disease is characterised by increased luminal diversity and stable mucosa-associated communities
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P677 It’s time to grow up: what is it like to transition from the paediatric to adult inflammatory bowel disease service?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P677: Azathioprine dosing and metabolite measurement in paediatric inflammatory bowel disease—does one size fit all?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P677: Combination of vedolizumab and exclusive enteral nutrition in patients with moderate to severe Crohn's Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P677: Effect of late faecal loss of infliximab on treatment response of inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P677: Fungal abundance is related to inflammatory status in Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P677: Impact of patient reported outcomes, coping strategies and psychosocial factors on medication adherence in inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM